an operator of a specialty immune globulin, development and commercialization of human plasma and plasma-derived therapeutics
Industry Biotechnology
A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with RCUS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then RCUS could also see price increases.
Ticker / NAME | Correlation To ADMA | 1D Price Change % | ||
---|---|---|---|---|
ADMA | 100% | -1.42% | ||
RCUS - ADMA | 40% Loosely correlated | -2.03% | ||
ACLX - ADMA | 37% Loosely correlated | -0.34% | ||
ITOS - ADMA | 37% Loosely correlated | -3.92% | ||
IMTX - ADMA | 36% Loosely correlated | +1.06% | ||
NVAX - ADMA | 35% Loosely correlated | -8.22% | ||
More |
Ticker / NAME | Correlation To ADMA | 1D Price Change % |
---|---|---|
ADMA | 100% | -1.42% |
drugs theme (254 stocks) | 41% Loosely correlated | -1.72% |
immune theme (11 stocks) | 33% Loosely correlated | -3.27% |
biotechnology theme (238 stocks) | 23% Poorly correlated | -1.80% |